Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bucher

Showing results (181-190 of 406) with videos related to

Pageof 41
Sort By:
Plos Medicine|February 27, 2010
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studiesMarcel Wolbers, Abdel Babiker, Caroline Sabin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 12, 1999
Rare AIDS-defining diseases in the Swiss HIV Cohort StudyB Burckhardt, P Sendi, D Pfluger, et al.
HIV Medicine|September 4, 2020
What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohortsA d'Arminio Monforte, F Bonnet, H C Bucher, et al.
Swiss Medical Weekly|November 19, 2018
Rationale and methods of an observational study to support the design of a nationwide surgical registry: the MIDAS studyWerner Vach, Franziska Saxer, Anders Holsgaard-Larsen, et al.
AIDS (London, England)|October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort StudyA C Friedl, B Ledergerber, M Flepp, et al.
JAMA|April 3, 1996
Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trialsH C Bucher, R J Cook, G H Guyatt, et al.
Antiviral Therapy|August 22, 2013
CD4(+) T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysisSteve Kanters, Jean Nachega, Anna Funk, et al.
Journal of Clinical Epidemiology|May 26, 2018
Off-label prescription: experience is a gloomy lantern that does not even illuminate its bearer. Author responseAviv Ladanie, John P A Ioannidis, Randall S Stafford, et al.
Clinical Chemistry and Laboratory Medicine|May 13, 2016
Copeptin predicts 10-year all-cause mortality in community patients: a 10-year prospective cohort studyJonas Odermatt, Rebekka Bolliger, Lara Hersberger, et al.
Journal of the International AIDS Society|August 4, 2017
Phased implementation of spaced clinic visits for stable HIV-positive patients in Rwanda to support Treat AllSabin Nsanzimana, Eric Remera, Muhayimpundu Ribakare, et al.
Pageof 41

Showing results (181-190 of 406) with videos related to

Sort By:
Pageof 41
Plos Medicine|February 27, 2010
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studiesMarcel Wolbers, Abdel Babiker, Caroline Sabin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 12, 1999
Rare AIDS-defining diseases in the Swiss HIV Cohort StudyB Burckhardt, P Sendi, D Pfluger, et al.
HIV Medicine|September 4, 2020
What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohortsA d'Arminio Monforte, F Bonnet, H C Bucher, et al.
Swiss Medical Weekly|November 19, 2018
Rationale and methods of an observational study to support the design of a nationwide surgical registry: the MIDAS studyWerner Vach, Franziska Saxer, Anders Holsgaard-Larsen, et al.
AIDS (London, England)|October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort StudyA C Friedl, B Ledergerber, M Flepp, et al.
JAMA|April 3, 1996
Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trialsH C Bucher, R J Cook, G H Guyatt, et al.
Antiviral Therapy|August 22, 2013
CD4(+) T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysisSteve Kanters, Jean Nachega, Anna Funk, et al.
Journal of Clinical Epidemiology|May 26, 2018
Off-label prescription: experience is a gloomy lantern that does not even illuminate its bearer. Author responseAviv Ladanie, John P A Ioannidis, Randall S Stafford, et al.
Clinical Chemistry and Laboratory Medicine|May 13, 2016
Copeptin predicts 10-year all-cause mortality in community patients: a 10-year prospective cohort studyJonas Odermatt, Rebekka Bolliger, Lara Hersberger, et al.
Journal of the International AIDS Society|August 4, 2017
Phased implementation of spaced clinic visits for stable HIV-positive patients in Rwanda to support Treat AllSabin Nsanzimana, Eric Remera, Muhayimpundu Ribakare, et al.
Pageof 41